TY  - JOUR

T1  - Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers

JO  - Vaccine

PY  - 2006/01/23

AU  - Cebere I

AU  - Dorrell L

AU  - McShane H

AU  - Simmons A

AU  - McCormack S

AU  - Schmidt C

AU  - Smith C

AU  - Brooks M

AU  - Roberts JE

AU  - Darwin SC

ED  - 

DO  - DOI: 10.1016/j.vaccine.2005.08.041

PB  - Elsevier BV

VL  - 24

IS  - 4

SP  - 417

EP  - 425

Y2  - 2024/12/28

ER  -